A “same-size bottle” can still be a different product decision.

The six-stage packaging change evidence chain

Twelve checks before approving a gummy packaging change

Change-impact matrix: ask different questions for different changes

What 21 CFR Part 111 establishes—and what your change record must connect

The dietary-supplement CGMP rule does not turn “change control” into a single checkbox. It establishes linked controls that make an unrecorded packaging substitution difficult to defend:

• Specifications: 21 CFR 111.70 includes specifications for labels, packaging that may contact dietary supplements, and the finished packaged and labeled supplement. Section 111.75 requires applicable specifications to be met.
• Quality control: 21 CFR 111.105 assigns quality-control personnel responsibilities for approving or rejecting processes, specifications, controls, tests, examinations, deviations and material-review/disposition decisions within the rule's scope.
• Incoming packaging and labels: 21 CFR 111.160 addresses examination, quarantine, representative sampling, quality-control review, release and unique lot identifiers.
• Controlled manufacturing instructions: 21 CFR 111.210 requires the master manufacturing record to include a packaging description and representative label—or controlled cross-references—plus instructions and applicable specifications.
• Batch traceability: 21 CFR 111.260 requires batch records to include the unique identifier assigned to packaging and labels used, among other production information.
• Packaging operations: 21 CFR 111.410 requires actions to determine whether packaging meets specifications, control of packaging and labels, pre-operation examination against the master record and the ability to determine complete manufacturing history and control through distribution.

A useful buyer record connects those controls to one concrete decision: what changed, what remained the same, which requirements could be affected, what evidence was reviewed, who approved implementation and how the effective lot can be identified.

Three defensible decision states

First production batch after the change

The change record should define what must be observed or measured on the first applicable commercial batch. Avoid vague instructions such as “QC to check packaging.” Name the component identifiers, approved revisions, examination, sample basis, acceptance criterion, record location, reviewer and disposition path.

1. Confirm status before use. Verify the new packaging and labels are the approved versions and have completed applicable incoming review and release.
2. Clear the line and old versions. Document pre-operation checks and controls used to prevent component or label mix-ups.
3. Record actual identifiers. Link the component and label lots used to the packaged batch and applicable supplier/site.
4. Verify setup and output. Record the defined line settings or checks and examine a representative packaged sample against the applicable specification.
5. Resolve discrepancies. Packaging/label issuance or use discrepancies, failed checks and deviations require documented review rather than silent adjustment.
6. Release and monitor. Record disposition and any post-change observations, complaints, retain-sample checks or stability commitments defined by the assessment.

Copy-ready packaging change evidence request

Questions to put into the supply agreement or purchase workflow

• Which packaging, label, component-supplier and manufacturing-site changes require advance notice?
• Who determines the evidence needed and who has final approval before implementation?
• How are emergency substitutions handled, documented and limited?
• What information accompanies each packaging lot and how is it linked to finished batches?
• How are obsolete labels and components segregated, reconciled and disposed of?
• Which stability, complaint or distribution signals trigger escalation after implementation?
• What change evidence may the brand review, retain or disclose to customers and regulators?

Related procurement tools

Primary sources and scope

• 21 CFR 111.70 — specifications
• 21 CFR 111.105 — quality-control responsibilities
• 21 CFR 111.160 — packaging and label receipt controls
• 21 CFR 111.210 — master manufacturing record
• 21 CFR 111.260 — batch production record
• 21 CFR 111.410 — packaging and labeling operations
• FDA — Dietary Supplement CGMP Small Entity Compliance Guide

Scope note: sources are linked so buyers can verify the current text. This page is educational procurement guidance, not legal advice, a claim that Sucotond has completed a change for a particular SKU, or evidence that any listed test is required for every change. Product-, market- and operation-specific responsibilities should be reviewed by qualified quality and regulatory personnel.